- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
Policy Recommendations Louisiana
2019-2020 Improvements and Recommendations for Louisiana
Louisiana continued to organize improvements to its limited medical cannabis program in 2020, with Governor Edwards signing HB 81922 into law. The bill eliminated the state's list of qualifying conditions, allowing doctors to recommend cannabis to patients as they see fit beginning on August 1, 2020. While the elimination of qualifying conditions is a huge stride for the Bayou State, significant work remains before the state's system is functional for patient use. One of the most important issues for lawmakers to tackle in 2021 is patient access, as authorized cannabis products did not begin to reach patients until August of 2019 at only nine approved pharmacies.
ASA recommends increasing the number of legal medical retailers from which patients can secure medicine, authorizing delivery of cannabis medicine to patients, as well as a caregiver system to support patient access. Improvements in patient protections are also called for, specifically related to employment, housing and parental rights, as are improvements in cultivation, testing laboratory and pharmacy operating procedures and staff training.
Responding to COVID Louisiana declared medical cannabis businesses essential, allowed for telehealth visits as a substitute for in-person patient evaluation and authorized licensed medical cannabis retailers to deliver to patients regardless of patient location.